Skip to main content
SYNTARA LIMITED logo

SYNTARA LIMITED — Investor Relations & Filings

Ticker · SNT ISIN · AU0000312480 LEI · 52990054L6XWT345FW20 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2026-05-18 Proxy Solicitation & In…
Country AU Australia
Listing ASX SNT

About SYNTARA LIMITED

https://syntaratx.com.au/

Syntara Limited is a clinical-stage drug development company focused on the discovery and development of novel small molecule therapeutics for inflammatory and fibrotic diseases. The company specializes in the inhibition of amine oxidase enzymes, including lysyl oxidase (LOX) and semicarbazide-sensitive amine oxidase (SSAO). Its primary clinical focus is on hematological malignancies and multi-organ fibrosis. The lead drug candidate, PXS-5505, is a pan-LOX inhibitor currently being evaluated for the treatment of myelofibrosis. Additionally, the company develops treatments for skin scarring, pulmonary fibrosis, and neurodegenerative conditions. Syntara leverages its proprietary drug discovery platform to address significant unmet medical needs through targeted enzymatic inhibition, aiming to modify disease progression in complex pathological environments.

Recent filings

Filing Released Lang Actions
Notice of General Meeting/Proxy Form 10 pages 853.7KB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of General Meeting accompanied by an Explanatory Statement and Proxy Voting Form. It outlines resolutions for shareholder approval (share placement Tranche 2 and ratification of Tranche 1), includes proxy appointment instructions, details on voting entitlements, and is intended to solicit proxies for a shareholder vote. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-18 English
Share Purchase Plan Offer Booklet 19 pages 328.7KB
Share Issue/Capital Change Classification · 85% confidence The document is an offer booklet outlining terms and conditions for a Share Purchase Plan (SPP), providing existing shareholders the opportunity to subscribe for new shares at a fixed issue price. It details the capital raising mechanics, key dates, eligibility criteria, and application process for the new share issuance. This is not an earnings release or regulatory certification but an announcement and documentation of a share issue under ASX Listing Rules. Therefore, it fits the “Share Issue/Capital Change” category.
2026-05-13 English
Update - Proposed issue of securities - SNT 6 pages 19.9KB
Share Issue/Capital Change Classification · 91% confidence The document is an ASX Listing Rule appendix (Appendix 3B) detailing the terms and timetable of a proposed issue of securities (a share purchase plan), including pricing, maximum number of shares, conditions and dates. This is a share issue/capital change announcement, not a financial report or regulatory certification. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-05-13 English
Change in substantial holding 7 pages 813.5KB
Major Shareholding Notification Classification · 95% confidence The document is a Form 604 “Notice of change of interests of substantial holder” under the Corporations Act 2001, detailing the dilution of a substantial holder’s share percentage and planned participation in a fundraising tranche. This is a disclosure of a change in significant share ownership levels, matching the Major Shareholding Notification category. It is not an earnings release, financial report, or management announcement but a regulatory notice of shareholding changes.
2026-05-11 English
Change in substantial holding 4 pages 91.7KB
Major Shareholding Notification Classification · 98% confidence The document is an Australian Corporations Act 2001 Form 604 “Notice of change of interests of substantial holder,” detailing Platinum Investment Management’s updated voting power, share acquisitions and disposals. This is a regulatory submission disclosing changes in significant shareholding, matching the Major Shareholding Notification category (MRQ).
2026-05-10 English
Application for quotation of securities - SNT 6 pages 18.4KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue price, and issued capital following quotation. It references a previous Appendix 3B announcement related to the securities issuance. The content is focused on the listing and quotation of new securities rather than a financial report or earnings release. This type of document is a regulatory announcement related to capital changes and securities issuance. According to the filing definitions, announcements regarding new share issues or capital changes fall under the category 'Share Issue/Capital Change' (SHA). The document length and content confirm it is not merely a brief announcement but a formal application for quotation, fitting the SHA category.
2026-05-06 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.